Genedata Profiler

Genedata Profiler is a commercial software product developed by Genedata AG, a Swiss life-sciences software company headquartered in Basel. The platform is designed for biopharmaceutical research organizations that need to ingest, curate, integrate, and analyze large volumes of heterogeneous R&D data — from genomics and transcriptomics to high-content imaging and clinical data — within a governed, collaborative environment. It is typically positioned as an enterprise data backbone for translational research, biomarker discovery, and precision medicine programs. The product is part of Genedata's broader portfolio of scientific software, which also includes solutions for biopharma process development, screening data analysis, and mass-spectrometry-based analytics. Genedata Profiler specifically targets the data-management and analytics layer of drug discovery and development, helping research teams replace fragmented spreadsheets and siloed databases with a scalable, auditable platform. It supports integration with common laboratory information management systems, instrument data formats, and public reference datasets, and provides role-based access controls and traceability features that are important in regulated research environments. Genedata sells Profiler primarily through direct enterprise licenses to large pharmaceutical companies, biotechnology firms, and academic research institutions. The company is privately held and does not disclose detailed financial results. Its customer base is global, with a strong presence in Europe and the United States. The brand is known within the life-sciences informatics community rather than among general consumers, and its market positioning emphasizes scientific depth, scalability, and support for collaborative research workflows.

Genedata AG was founded in 1997 in Basel, Switzerland, as a spin-off from the Swiss Federal Institute of Technology (ETH) and the University of Basel, with a focus on computational biology and software for the life sciences. The company initially built tools for analyzing high-throughput screening data and gradually expanded into other areas of biopharma R&D, including process development and mass spectrometry. Genedata Profiler was developed as part of this expansion, addressing the growing need among pharmaceutical companies to manage and analyze large, diverse datasets generated by genomics, proteomics, and other omics technologies. The platform has been adopted by major pharmaceutical and biotechnology companies for translational research and biomarker discovery. Genedata remains a privately held company and continues to develop and support Profiler as part of its portfolio of scientific software solutions.

Enterprise-grade software for biopharma R&D data integration and analytics.

• Genedata Profiler

  Enterprise software platform for biopharma R&D data management and analytics.

• 2026.08.13

  Reported2026.08.13

  Genedata launches Biomarker Discovery Agent in Genedata Profiler[1]Genedata在Genedata Profiler中推出生物标志物发现AI代理prnewswire.com

  Genedata, a Danaher company, announced a new AI agent in Genedata Profiler, its enterprise platform for integrating and analyzing translational and clinical research data, expanding AI-driven biomarker discovery capabilities. In collaboration with Washington University School of Medicine in St. Louis, the agent was used to identify a five-protein blood-based model for Alzheimer's disease validated in an independent cohort.

Read more

1. 1Genedata在Genedata Profiler中推出生物标志物发现AI代理prnewswire.com